Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis
The treatment strategy for cases of combined autoimmune hepatitis (AIH) and chronic hepatitis C (CHC) has not yet been established. A 47-year-old woman and a 53-year-old-woman were hospitalized for treatment of CHC. Ultrasonography and histological findings revealed that their liver was not cirrhoti...
Main Authors: | Oeda, Satoshi, Mizuta, Toshihiko, Isoda, Hiroshi, Kuwashiro, Takuya, Oza, Noriko, Iwane, Shinji, Takahashi, Hirokazu, Kawaguchi, Yasunori, Eguchi, Yuichiro, Toda, Shuji, Ozaki, Iwata, Anzai, Keizo, Fujimoto, Kazuma |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Japan
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328672/ |
Similar Items
-
Optimal Follow-up of Patients with Viral Hepatitis Improves the Detection of Early-stage Hepatocellular Carcinoma and the Prognosis of Survival
by: Oeda, Satoshi, et al.
Published: (2016) -
Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
by: Aizawa, Nobuhiro, et al.
Published: (2013) -
Evaluation narcotic analgesic use and survival time in terminal stage liver diseases compared with lung cancer: a retrospective chart review
by: Nakashita, Shunya, et al.
Published: (2013) -
Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
by: Takayama, Tetsuro, et al.
Published: (2011) -
Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients
by: Aghemo, Alessio, et al.
Published: (2011)